Citation Impact
Citing Papers
Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis
2008
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
2014
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Breast cancer
2019 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States
2015
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
QuPath: Open source software for digital pathology image analysis
2017 Standout
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
2010
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Role of Gemcitabine in Breast Cancer Management: An Update
2006
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Marine natural products
1990 Standout
Lung Cancer
2008 Standout
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Cancer of unknown primary (CUP)
2005
Current Strategies in Whole-brain Radiation Therapy for Brain Metastases
2005
Lung cancer: current therapies and new targeted treatments
2016 Standout
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Diagnostic and therapeutic management of cancer of an unknown primary
2003
Nasopharyngeal carcinoma
2015 Standout
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
2014
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Management of brain metastases
2004
Current and future developments in the use of temozolomide for the treatment of brain tumours
2001
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the seventh world conference on lung cancer
1995
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
2011
MicroRNA signatures in human cancers
2006 Standout
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes
2010
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Factors affecting the prognosis of breast cancer patients with brain metastases
2008
Small-cell lung cancer
2005
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Small Cell Lung Cancer
2008
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011
2012
Anemia of Chronic Disease
2005 Standout
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
1998
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
1999
Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
2012
Chemotherapy for advanced gastric cancer
2017 Standout
Breast Cancer Treatment
2019 Standout
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
2017
Determination of the absolute configuration and evaluation of the in vitro antitumor activity of dilospirane B
2012
Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study
2004
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute
2012
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer
2009
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma
2003
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Medical Management of Brain Metastases and Leptomeningeal Disease in Patients with Breast Carcinoma
2018
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
2014
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
CNS Metastases in Breast Cancer
2004
Works of E. Samantas being referenced
Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.
1998
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
2006
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
2010
HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma
2008
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women
2005
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
2000
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
2010
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
2001
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
2012
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer
1994
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
2001
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
2008
Combination Regimen with Carboplatin, Epirubicin and Etoposide in Metastatic Carcinomas of Unknown Primary Site: A Hellenic Co-Operative Oncology Group Phase II Study
1998
Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation
2008
Cisplatin/ifosfamide/vinblastine (VIP) vs, cisplatin/ifosfamide etoposide (VIR-16) in non-small cell lung cancer (NSCLC). A prospective randomized phase III study
1994
Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study
2000
Temozolomide in Combination With Docetaxel in Patients With Advanced Melanoma: A Phase II Study of the Hellenic Cooperative Oncology Group
2002
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
2012